Trial intelligence / Profile preview

Liraglutide for perioperative hyperglycemia management during cardiac surgery

NL-OMON45357Phase 4Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Jun 2017
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised trial in hyperglycemia comparing Liraglutide with Placebo (2 arms). Primary endpoint: Reduction in the number of patients needing perioperative insulin treatment. Started Jun 2017; status: active, not recruiting.

02

Drugs

03

Conditions

hyperglycemia

Beyond the preview

Go deeper on NL-OMON45357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call